Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Rojas, Mauricio  [Clear All Filters]
2024
Dagher R, Moldobaeva A, Gubbins E, Clark S, Alfajaro MMadel, Wilen CB, Hawkins F, Qu X, Chiang CChien, Li Y, et al. Human iPSC-based model of COPD to investigate disease mechanisms, predict SARS-COV-2 outcome and test preventive immunotherapy. Stem Cells. 2024.
2023
Kruk D, C Y Yeung A, Faiz A, Hacken NHTTen, Timens W, van Kuppevelt TH, Daamen W, Hof D, Harmsen MC, Rojas M, et al. Gene expression profiles in mesenchymal stromal cells from bone marrow, adipose tissue and lung tissue of COPD patients and controls. Respir Res. 2023;24(1):22.
2021
Culley MK, Zhao J, Tai YYin, Tang Y, Perk D, Negi V, Yu Q, Woodcock C-SC, Handen A, Speyer G, et al. Frataxin deficiency promotes endothelial senescence in pulmonary hypertension. J Clin Invest. 2021.
2019
Lee EJoo, Cárdenes N, Álvarez D, Sellares J, Sembrat J, Aranda P, Peng Y, Bullock J, Nouraie SM, Mora AL, et al. Mesenchymal stem cells reduce ER stress via PERK-Nrf2 pathway in an aged mouse model. Respirology. 2019.
2014
Ubil E, Duan J, Pillai ICL, Rosa-Garrido M, Wu Y, Bargiacchi F, Lu Y, Stanbouly S, Huang J, Rojas M, et al. Mesenchymal-endothelial transition contributes to cardiac neovascularization. Nature. 2014.
2013
Bustos ML, Huleihel L, Meyer EM, Donnenberg AD, Donnenberg VS, Sciurba JD, Mroz L, McVerry BJ, Ellis BM, Kaminski N, et al. Activation of Human Mesenchymal Stem Cells Impacts Their Therapeutic Abilities in Lung Injury by Increasing Interleukin (IL)-10 and IL-1RN Levels. Stem Cells Transl Med. 2013.
Shu H-KG, Yoon Y, Hong S, Xu K, Gao H, Hao C, Torres-Gonzalez E, Nayra C, Rojas M, Shim H. Inhibition of the CXCL12/CXCR4-Axis as Preventive Therapy for Radiation-Induced Pulmonary Fibrosis. PLoS One. 2013;8(11):e79768.
Zheng G-P, Ge M-H, Shu Q, Rojas M, Xu J. Mesenchymal stem cells in the treatment of pediatric diseases. World J Pediatr. 2013;9(3):197-211.